Omada Health CAO sells 644 shares at $21.73

Q: What insider transaction did OMDA disclose for Gracey Craig?

Omada Health disclosed that Chief Accounting Officer Gracey Craig sold 644 shares of common stock on September 9, 2026 at a weighted average price of $21.73 per share, leaving her with 14,412 shares held directly after the transaction.

Q: Was the OMDA insider sale by Gracey Craig under a Rule 10b5-1 plan?

Yes. The sale of 644 shares of Omada Health common stock by Chief Accounting Officer Gracey Craig on September 9, 2026 was made pursuant to a Rule 10b5-1 trading plan that she adopted on March 13, 2026.

Q: How many OMDA shares did Gracey Craig retain after the reported sale?

After selling 644 shares of Omada Health common stock, Chief Accounting Officer Gracey Craig held 14,412 shares directly. This figure reflects her direct ownership position immediately following the reported transaction on September 9, 2026.

Q: What price did the OMDA shares sell for in Gracey Craig’s transaction?

The 644 shares of Omada Health common stock sold by Chief Accounting Officer Gracey Craig on September 9, 2026 were reported at a weighted average sale price of $21.73 per share in an open-market or private transaction.

Q: What is Gracey Craig’s role at OMDA in this Form 4 filing?

In this Form 4, Gracey Craig is identified as Omada Health’s Chief Accounting Officer. She reported a sale of 644 shares of the company’s common stock under a Rule 10b5-1 trading plan, with 14,412 shares remaining under her direct ownership afterward.

Omada Health’s chief accounting officer sold a small block of shares under a pre-arranged Rule 10b5-1 trading plan, retaining over fourteen thousand shares afterward.

Available on EDGAR 09/11/2026 - 04:46 PM EDT Accepted by SEC EDGAR 09/11/2026 - 04:45 PM EDT

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Omada Health, Inc. (OMDA) reported that its Chief Accounting Officer, Gracey Craig, sold 644 shares of common stock on September 9, 2026 at a weighted average price of $21.73 per share in an open-market or private transaction. The sale was made pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2026, and left her with 14,412 shares of common stock held directly.

Insider Trade Summary 10b5-1

Net Seller: 644 shares

Net Sell 1 txn

Insider Gracey Craig

Role Chief Accounting Officer

Sold 644 shs ($14K)

Share of Position Sold 4.3%

Type	Security	Shares	Price	Value
Sale	Common Stock ^F1	644	$21.7316	$14K

Holdings After Transaction: Common Stock — 14,412 shares (Direct)

Holdings Before and After: Common Stock, 15,056 to 14,412 shares (Direct)

Other Insiders: 3 other insiders reported open-market sales of this stock in the 30 days up to this filing.

Footnotes (1)

F1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

Key Figures

Shares sold: 644 shares Sale price: $21.73 per share Shares held after transaction: 14,412 shares +2 more

5 metrics

Shares sold 644 shares Common stock sold by Chief Accounting Officer on September 9, 2026

Sale price $21.73 per share Weighted average price for the 644 shares sold on September 9, 2026

Shares held after transaction 14,412 shares Direct ownership by Chief Accounting Officer after the September 9, 2026 sale

Rule 10b5-1 plan adoption date March 13, 2026 Date the trading plan governing the reported sale was adopted

Net shares sold in filing 644 shares Total net shares sold across all reported transactions in this Form 4

Key Terms

Rule 10b5-1 trading plan, open market, private transaction

3 terms

Rule 10b5-1 trading plan regulatory

"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

open market market

"Sale in open market or private transaction"

An open market is a system where buying and selling of goods, services, or financial assets happen freely without restrictions or special controls. For investors, it means they can trade assets easily and quickly, which helps determine fair prices based on supply and demand. This environment encourages transparency and competition, making it easier to buy or sell with confidence.

private transaction market

"Sale in open market or private transaction"

A private transaction is the sale or transfer of securities, assets, or ownership stakes carried out directly between a small number of parties rather than on a public exchange. For investors it matters because these deals are less visible and often less liquid than public trades, so pricing can be harder to verify, the investment can be harder to sell quickly, and buyers or sellers may gain strategic advantages not available in open markets — like negotiated terms similar to a private garage sale versus a crowded marketplace.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did OMDA disclose for Gracey Craig?

Omada Health disclosed that Chief Accounting Officer Gracey Craig sold 644 shares of common stock on September 9, 2026 at a weighted average price of $21.73 per share, leaving her with 14,412 shares held directly after the transaction.

Was the OMDA insider sale by Gracey Craig under a Rule 10b5-1 plan?

Yes. The sale of 644 shares of Omada Health common stock by Chief Accounting Officer Gracey Craig on September 9, 2026 was made pursuant to a Rule 10b5-1 trading plan that she adopted on March 13, 2026.

How many OMDA shares did Gracey Craig retain after the reported sale?

After selling 644 shares of Omada Health common stock, Chief Accounting Officer Gracey Craig held 14,412 shares directly. This figure reflects her direct ownership position immediately following the reported transaction on September 9, 2026.

What price did the OMDA shares sell for in Gracey Craig’s transaction?

The 644 shares of Omada Health common stock sold by Chief Accounting Officer Gracey Craig on September 9, 2026 were reported at a weighted average sale price of $21.73 per share in an open-market or private transaction.

What is Gracey Craig’s role at OMDA in this Form 4 filing?

In this Form 4, Gracey Craig is identified as Omada Health’s Chief Accounting Officer. She reported a sale of 644 shares of the company’s common stock under a Rule 10b5-1 trading plan, with 14,412 shares remaining under her direct ownership afterward.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gracey Craig

(Last)

(First)

(Middle)

C/O OMADA HEALTH, INC.

611 GATEWAY BLVD, SUITE 120

(Street)

SOUTH SAN FRANCISCO

CALIFORNIA

94080

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Omada Health, Inc. [ OMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Accounting Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	09/09/2026		S⁽¹⁾		644	D	$21.7316	14,412	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

	/s/ Nathan Salha, as Attorney-in-Fact for Craig Gracey	09/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR